Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Marchex (MCHX) Research & Development (2016 - 2025)

Marchex (MCHX) has disclosed Research & Development for 16 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • For Q4 2025, Research & Development fell 22.39% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $9.7 million, down 21.49%, while the annual FY2025 figure was $9.7 million, 21.48% down from the prior year.
  • Research & Development was $2.2 million for Q4 2025 at Marchex, down from $2.4 million in the prior quarter.
  • The five-year high for Research & Development was $5.3 million in Q1 2021, with the low at $2.2 million in Q4 2025.
  • Historically, Research & Development has averaged $3.4 million across 5 years, with a median of $3.2 million in 2024.
  • The largest annual shift saw Research & Development tumbled 45.39% in 2021 before it surged 36.03% in 2022.
  • Over 5 years, Research & Development stood at $2.8 million in 2021, then surged by 36.03% to $3.8 million in 2022, then fell by 17.89% to $3.2 million in 2023, then decreased by 9.9% to $2.8 million in 2024, then dropped by 22.39% to $2.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $2.2 million in Q4 2025, $2.4 million in Q3 2025, and $2.5 million in Q2 2025.